Table 2.
Patient and tumor characteristics
| Characteristics (n=52) | |
|---|---|
| Age | |
| Median | 58.8 |
| Range | 29.5–85.6 |
| Sex | |
| Male | 26 (50%) |
| Female | 26 (50%) |
| Race | |
| White | 37 (71%) |
| Black | 6 (12%) |
| Asian | 6 (12%) |
| Native American | 1 (2%) |
| Unknown | 2 (4%) |
| Ethnicity | |
| Non-hispanic | 47 (90%) |
| Hispanic | 4 (8%) |
| unknown | 1 (2%) |
| Zubrod Performance Status | |
| 0 | 18 (35%) |
| 1 | 26 (50%) |
| 2 | 8 (15%) |
| Primary Site | |
| Cholangiocarcinoma | 35 (67%) |
| Gallbladder Cancer | 17 (33%) |
| Site of metastasis | |
| Liver | 45 (87%) |
| Lung | 16 (31%) |
| Abdominal disease ?peritoneal | 12 (23%) |
| Regional Lymph nodes | 21 (40%) |
| Prior Surgery | 23 (44%) |
| Prior Adjuvant Therapy | |
| Radiation | 3 (6%) |
| Chemotherapy | 2 (4%) |